3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain

3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.

Diego Bochoeyer is a biologist with molecular genetics and biotechnology specialization and a business background. With more than 17 years of experience in the global biotech sector – from Buenos Aires to Copenhagen to Seattle, he has demonstrated successful executive leadership in the biotech industry.

CDMO Supply Chain expertise as 3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain

With this new appointment, 3P moves forward with its ambitious growth plan to consolidate its competitive position as one of Europe’s leading CDMOs”, explains 3P’s CEO, Dámaso Molero.

I’m thrilled to join the 3P Biopharmaceuticals team and I am grateful to have the opportunity to build and develop a strategy that will enable 3P to further its position as a leading European CDMO”, stated Diego on his arrival at the Noain-based company. “My goal at first is to understand the challenges throughout all of the teams at 3P. Second is to enhance and improve strategic operations across each department to ensure cross-functional excellence”, he added.

Diego Bochoeyer started his career in 2004 in Buenos Aires in animal vaccine production where, for 5 years, he worked with large-scale manufacturing of inactivated viruses and bacterial vaccines along with recombinant protein and DNA vaccines at development scale. Since then, he has worked for several companies and has become a successful executive leader in large manufacturing organizations like AGC Biologics, a worldwide leading CDMO, where he operated for almost a decade in different roles in operations acting as VP Vice President of Manufacturing for 3 years before becoming Global Process Engineering Director, in Seattle (USA).

Dámaso Molero, CEO of 3P Biopharmaceuticals said: “We are delighted to bring Diego Bochoeyer on to our team. His mammalian and microbial protein manufacturing expertise, driving cGMP upstream and downstream operations, and building additional facilities to bring them to cGMP standards, both in large capital projects and minor expansions, will have a vital impact on our organization. His core mission will be guiding operational readiness teams and building strategies throughout the organization to enable 3P to grow and expand to fit our customer’s needs”.

View the full press release here

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email itswithinus@3pbio.com

Related Content

Osivax and 3P Biopharmaceuticals team up to develop a new universal vaccine against current and future variants of SARS-COV-2

Osivax's novel oligoDOM® technology, designed to induce potent T-cell responses, will serve as the basis for this broad-spectrum vaccine against COVID-19
Read more

Elena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE

Elena Erroba, Director of Business Development, Communication and Marketing at 3P Biopharmaceuticals, has been elected as Navarra’s Businesswoman of the Year 2021
Read more

3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA

The investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total floor space of the company will triple.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.